Authors:
Puoti, M
Cadeo, GP
Putzolu, V
Forleo, MA
Barni, MC
Cristini, G
Rossi, S
Spinetti, A
Zaltron, S
Zanini, B
Quiros-Roldan, E
Paraninfo, G
Gargiulo, F
Carosi, G
Citation: M. Puoti et al., Pilot dose-finding trial on interferon alpha in combination with ribavirinfor the treatment of chronic hepatitis C in patients not responding to interferon alone, DIG LIVER D, 33(2), 2001, pp. 163-172
Authors:
Girardi, E
Aloisi, MS
Serraino, D
Ferrara, M
Lauria, FN
Carballo, M
Monforte, AD
Rezza, G
Moroni, M
Carosi, G
Alessandrini, A
Giacobbi, D
Cremonini, L
Ranieri, S
Montroni, M
Ippolito, G
Citation: E. Girardi et al., Sexual behaviour of heterosexual individuals with HIV infection naive for antiretroviral therapy in Italy, SEX TRANS I, 77(2), 2001, pp. 130-134
Authors:
Sica, C
Novara, C
Carosi, G
Casari, S
Dorz, S
Nasta, P
Sanavio, E
Citation: C. Sica et al., Predicting health distress and at-risk sexual behaviour in a group of Italian asymptomatic HIV-infected people, CLIN PSY PS, 8(1), 2001, pp. 49-58
Authors:
Ally, R
Schurmann, D
Kreisel, W
Carosi, G
Aguirrebengoa, K
Dupont, B
Hodges, M
Troke, P
Romero, AJ
Citation: R. Ally et al., A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients, CLIN INF D, 33(9), 2001, pp. 1447-1454
Authors:
Viale, P
Petrosillo, N
Signorini, L
Puoti, M
Carosi, G
Citation: P. Viale et al., Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections?, CLIN INF D, 33(11), 2001, pp. 1947-1948
Authors:
El-Hamad, I
Casalini, C
Matteelli, A
Casari, S
Bugiani, M
Caputo, M
Bombana, E
Scolari, C
Moioli, R
Scarcella, C
Carosi, G
Citation: I. El-hamad et al., Screening for tuberculosis and latent tuberculosis infection among undocumented immigrants at an unspecialised health service unit, INT J TUBE, 5(8), 2001, pp. 712-716
Authors:
Quiros-Roldan, E
Moretti, F
Airoldi, M
Fausti, C
Chiodera, A
Castelli, F
Carosi, G
Citation: E. Quiros-roldan et al., Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients, J CL LAB AN, 15(3), 2001, pp. 127-130
Authors:
Matteelli, A
Beltrame, A
Graifemberghi, S
Forleo, MA
Gulletta, M
Ciravolo, G
Tedoldi, S
Casalini, C
Carosi, G
Citation: A. Matteelli et al., Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons, SEX TRA DIS, 28(6), 2001, pp. 343-346
Authors:
Villani, P
Viale, P
Signorini, L
Cadeo, B
Marchetti, F
Villani, A
Fiocchi, C
Regazzi, MB
Carosi, G
Citation: P. Villani et al., Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy, ANTIM AG CH, 45(7), 2001, pp. 2160-2162
Authors:
Quiros-Roldan, E
Bertelli, D
Signorini, S
Airoldi, M
Torti, C
Moretti, F
Carosi, G
Citation: E. Quiros-roldan et al., HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatment, MICROBIOS, 106(414), 2001, pp. 137-145
Authors:
Puoti, M
Bonacini, M
Spinetti, A
Putzolu, V
Govindarajan, S
Zaltron, S
Favret, M
Callea, F
Gargiulo, F
Donato, F
Carosi, G
Citation: M. Puoti et al., Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus, J INFEC DIS, 183(1), 2001, pp. 134-137
Authors:
Re, A
Casari, S
Cattaneo, C
Facchetti, F
Cadeo, G
Carosi, G
Rossi, G
Citation: A. Re et al., Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-hodgkin lymphoma, CANCER, 92(11), 2001, pp. 2739-2745
Authors:
Matteelli, A
Kassa, A
Gerbase, A
Farina, C
Ghidinelli, M
Chatel, G
Beltrame, A
Feleke, W
Carosi, G
Citation: A. Matteelli et al., Passive sentinel surveillance system for sexually transmitted diseases in primary healthcare sites in Ethiopia, 1991-3, SEX TRANS I, 76(2), 2000, pp. 131-133
Authors:
Matteelli, A
Casalini, C
Raviglione, MC
El-Hamad, I
Scolari, C
Bombana, E
Bugiani, M
Caputo, M
Scarcella, C
Carosi, G
Citation: A. Matteelli et al., Supervised preventive therapy for latent tuberculosis infection in illegalimmigrants in Italy, AM J R CRIT, 162(5), 2000, pp. 1653-1655
Authors:
Airo, P
Torti, C
Uccelli, MC
Malacarne, F
Palvarini, L
Carosi, G
Castelli, F
Citation: P. Airo et al., Naive CD4(+) T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection, AIDS RES H, 16(17), 2000, pp. 1805-1807
Authors:
Floridia, M
Tomino, C
Bucciardini, R
Ricciardulli, D
Fragola, V
Pirillo, MF
Amici, R
Giannini, G
Galluzzo, CM
Andreotti, M
Seeber, AC
Ammassari, A
Cingolani, A
Lazzarin, A
Scalise, G
Cargnel, A
Suter, F
Milazzo, F
Pastore, G
Moroni, M
Ciammarughi, R
Pini, R
Carosi, G
D'Amato, C
Contu, L
Concia, E
Bonazzi, L
Aiuti, F
Vigevani, G
Vella, S
Citation: M. Floridia et al., A randomized trial comparing the introduction of ritonavir or indinavir in1251 nucleoside-experienced patients with advanced HIV infection, AIDS RES H, 16(17), 2000, pp. 1809-1820
Authors:
Magalini, A
Puoti, M
Putzolu, V
Quiros-Roldan, E
Forleo, MA
Rossi, S
Zaltron, S
Spinetti, A
Zanini, B
Zonaro, A
Solfrini, R
Carosi, G
Citation: A. Magalini et al., Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month, J CL LAB AN, 14(3), 2000, pp. 120-124
Authors:
Clerici, M
Seminari, E
Suter, F
Castelli, F
Pan, A
Biasin, M
Colombo, F
Trabattoni, D
Maggiolo, F
Carosi, G
Maserati, R
Citation: M. Clerici et al., Different immunologic profiles characterize HIV infection in highly activeantiretroviral therapy-treated and antiretroviral-naive patients with undetectable viraemia, AIDS, 14(2), 2000, pp. 109-116
Authors:
Puoti, M
Gargiulo, F
Roldan, EQ
Chiodera, A
Palvarini, L
Spinetti, A
Zaltron, S
Putzolu, V
Zanini, B
Favilli, F
Turano, A
Carosi, G
Citation: M. Puoti et al., Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment, J INFEC DIS, 181(6), 2000, pp. 2033-2036
Authors:
Chatel, G
Scolari, C
Gulletta, M
Casalini, C
Carosi, G
Citation: G. Chatel et al., Efficacy and tolerability of thiabendazole in a lipophil vehicle for cutaneous larva migrans, ARCH DERMAT, 136(9), 2000, pp. 1174-1175
Authors:
Matteelli, A
Colombini, P
Gulletta, M
Castelli, F
Carosi, G
Citation: A. Matteelli et al., Epidemiological features and case management practices of imported malariain northern Italy 1991-1995, TR MED I H, 4(10), 1999, pp. 653-657